HT-06

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHT-06
Drug Alias Namebis catechol-loracarbef conjugate (Hsiri Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcinetobacter Baumannii Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHsiri Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHsiri Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAcinetobacter Baumannii Infections

Other Information

ATC CodeN/A
Related LinksN/A